Ronald Blue Trust, Inc. Novartis Ag Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 7,086 shares of NVS stock, worth $747,431. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,086
Previous 14,449
50.96%
Holding current value
$747,431
Previous $1.41 Million
51.0%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
133MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.27 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$854 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$737 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$609 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...